Soluble HLA antigens in the circulation of liver graft recipients
- PMID: 2646783
- DOI: 10.1097/00007890-198903000-00025
Soluble HLA antigens in the circulation of liver graft recipients
Abstract
Human liver allografts deliver soluble class I (HLA-A and -B) transplantation antigens into the recipients' circulation. These molecules are detectable in recipient serum shortly after transplantation and they persist at high concentration for as long as the liver graft functions. Levels of graft-derived antigens in the recipient serum and self antigens in donor serum are comparable. Kinetic studies of these soluble antigens in donor and recipient show that donor antigens are continuously exported by the transplanted liver, while in the recipient, self antigens are derived from liver and other sources. At least two molecular forms of soluble HLA-A and -B antigens are present in sera from donors, recipients, and normal individuals. One form with m.w. approximately 50 kd seems to be a soluble monomer associated with beta 2-microglobulin, while the other forms of higher m.w. may be aggregates and/or complexes. Monitoring of these antigens in transplant recipients may be a useful indicator of graft pathology and function.
Similar articles
-
Donor-derived soluble HLA plasma levels can not be used to monitor graft rejection in heart transplant recipients.Transpl Immunol. 2000 Mar;8(1):57-64. doi: 10.1016/s0966-3274(00)00009-5. Transpl Immunol. 2000. PMID: 10834611
-
Evaluation of pretransplant donor anti-recipient cytotoxic and helper T lymphocyte responses as correlates of acute graft-vs.-host disease and survival after unrelated marrow transplantation.Biol Blood Marrow Transplant. 1997 Aug;3(3):142-9. Biol Blood Marrow Transplant. 1997. PMID: 9310191
-
Serologic allogeneic chimerism.Transplantation. 1997 Sep 27;64(6):865-71. doi: 10.1097/00007890-199709270-00013. Transplantation. 1997. PMID: 9326412
-
Soluble HLA antigens, anti-HLA antibodies, and antiidiotypic antibodies in the circulation of renal transplant recipients.Transplantation. 1991 Mar;51(3):593-601. doi: 10.1097/00007890-199103000-00011. Transplantation. 1991. PMID: 2006515
-
Soluble HLA: patterns of expression in normal subjects, autoimmune diseases, and transplant recipients.Rheumatol Int. 2005 Sep;25(7):491-500. doi: 10.1007/s00296-005-0585-y. Epub 2005 Jun 29. Rheumatol Int. 2005. PMID: 15986087 Review. No abstract available.
Cited by
-
Saliva soluble HLA as a potential marker of response to interferon-beta 1a in multiple sclerosis: a preliminary study.J Neuroinflammation. 2007 Jul 1;4:16. doi: 10.1186/1742-2094-4-16. J Neuroinflammation. 2007. PMID: 17601341 Free PMC article.
-
Chronic rejection. A general overview of histopathology and pathophysiology with emphasis on liver, heart and intestinal allografts.Ann Transplant. 1997;2(2):27-44. Ann Transplant. 1997. PMID: 9869851 Free PMC article. Review. No abstract available.
-
Small bowel transplantation. A life-saving option for selected patients with intestinal failure.Dig Dis Sci. 1996 May;41(5):875-83. doi: 10.1007/BF02091526. Dig Dis Sci. 1996. PMID: 8625758
-
The Human Immune Response to Cadaveric and Living Donor Liver Allografts.Front Immunol. 2020 Jun 22;11:1227. doi: 10.3389/fimmu.2020.01227. eCollection 2020. Front Immunol. 2020. PMID: 32655558 Free PMC article. Review.
-
The Role of Humoral Alloreactivity in Liver Transplantation: Lessons Learned and New Perspectives.J Immunol Res. 2017;2017:3234906. doi: 10.1155/2017/3234906. Epub 2017 Jan 9. J Immunol Res. 2017. PMID: 28164136 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials